Search

Your search keyword '"Tumors -- Drug therapy -- Genetic aspects"' showing total 3 results
Start Over Descriptor "Tumors -- Drug therapy -- Genetic aspects" Journal legal monitor worldwide
3 results on '"Tumors -- Drug therapy -- Genetic aspects"'

1. Senhwa Announces Multiple IND Application Submissions to US FDA and Health Canada for the Treatment of Solid Tumors with BRCA2 or PALB2 Mutations

Subjects
United States. Food and Drug Administration, Cancer treatment, Talazoparib, Cancer research -- Genetic aspects, Tumors -- Drug therapy -- Genetic aspects, Business, international, Law
Abstract

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that it has submitted multiple Investigational [...]

Published
2020

2. PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation

Subjects
United States. Food and Drug Administration, Cancer treatment, Tumor proteins -- Genetic aspects -- Drug therapy, Tumors -- Drug therapy -- Genetic aspects, Cancer patients -- Drug therapy, Drug approval, Business, international, Law
Abstract

(GlobeNewswire) - PMV Pharmaceuticals, Inc., (Nasdaq: PMVP) a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, today announced that the U.S. Food [...]

Published
2020

3. Turning Point Therapeutics Granted Fast-Track Designation for Repotrectinib in NTRK-Positive TKI-Pretreated Advanced Solid Tumors

Subjects
United States. Food and Drug Administration, Chemotherapy, Tumors -- Drug therapy -- Genetic aspects, Business, international, Law
Abstract

(GlobeNewswire) - Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the Food and Drug Administration (FDA) granted [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results